Education
About Us
Working with TipRanks
Follow Us
Firebrick Pharma Limited (AU:FRE)
ASX:FRE
Total Valuation
Firebrick Pharma Limited has a market cap or net worth of ―. The enterprise value is AU$9.71M.
Market Cap―
Enterprise ValueAU$9.71M
Share Statistics
Firebrick Pharma Limited has 224,576,460 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding224,576,460
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Firebrick Pharma Limited’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Firebrick Pharma Limited is ―. Firebrick Pharma Limited’s PEG ratio is ―.
PE Ratio―
PS Ratio5509.52
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Firebrick Pharma Limited had revenue of 14.52K and earned -1.18M in profits. Earnings per share was -0.01.
Revenue14.52K
Gross Profit-22.78K
Operating Income-944.05K
Pretax Income-1.18M
Net Income-1.18M
EBITDA-1.08M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -2.85M and capital expenditures -196.00, giving a free cash flow of -2.85M billion.
Operating Cash Flow-2.85M
Free Cash Flow-2.85M
Free Cash Flow per Share-0.01
Dividends & Yields
Firebrick Pharma Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.77
52-Week Price Change33.33%
50-Day Moving Average0.09
200-Day Moving Average0.07
Relative Strength Index (RSI)33.04
Average Volume (3m)92.67K
Important Dates
Firebrick Pharma Limited upcoming earnings date is Aug 28, 2025, TBA Not Confirmed.
Last Earnings DateFeb 25, 2025
Next Earnings DateAug 28, 2025
Ex-Dividend Date―
Financial Position
Firebrick Pharma Limited as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Firebrick Pharma Limited has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate―
Enterprise Valuation
Firebrick Pharma Limited EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Firebrick Pharma Limited has AU$824.78K in cash and marketable securities with AU$0.00 in debt, giving a net cash position of -AU$824.78K billion.
Cash & Marketable SecuritiesAU$824.78K
Total DebtAU$0.00
Net Cash-AU$824.78K
Net Cash Per Share>-AU$0.01
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Firebrick Pharma Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast67.55%